National Health Investors (NYSE:NHI) Posts Quarterly Earnings Results

National Health Investors (NYSE:NHI) issued its earnings results on Tuesday. The real estate investment trust reported $0.65 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.42), Zacks reports. The business had revenue of $63.32 million for the quarter, compared to the consensus estimate of $67.93 million. National Health Investors had a net margin of 39.11% and a return on equity of 10.11%. The business’s revenue was up 1.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.08 EPS. National Health Investors updated its FY24 guidance to $4.43-$4.44 EPS and its FY 2024 guidance to 4.430-4.440 EPS.

National Health Investors Stock Up 3.8 %

Shares of National Health Investors stock traded up $2.88 during trading hours on Thursday, reaching $79.64. 451,097 shares of the company’s stock were exchanged, compared to its average volume of 194,790. The company has a current ratio of 10.27, a quick ratio of 10.27 and a debt-to-equity ratio of 0.91. The company has a 50 day moving average of $80.38 and a two-hundred day moving average of $73.16. The stock has a market cap of $3.46 billion, a P/E ratio of 27.07, a P/E/G ratio of 5.05 and a beta of 1.05. National Health Investors has a fifty-two week low of $49.25 and a fifty-two week high of $86.13.

National Health Investors Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 29th. Stockholders of record on Tuesday, December 31st will be paid a dividend of $0.90 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.52%. National Health Investors’s dividend payout ratio is 122.45%.

Wall Street Analysts Forecast Growth

Several analysts have commented on NHI shares. StockNews.com cut shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th. Wells Fargo & Company lowered shares of National Health Investors from an “overweight” rating to an “equal weight” rating and boosted their price target for the company from $81.00 to $86.00 in a report on Tuesday, October 1st. Truist Financial boosted their price target on shares of National Health Investors from $65.00 to $78.00 and gave the company a “hold” rating in a report on Friday, August 30th. Finally, Bank of America started coverage on shares of National Health Investors in a report on Tuesday, September 24th. They issued a “buy” rating and a $92.00 price target for the company. Four research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $73.29.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.